Insulet CorporationPODDNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+21.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+21.1%/yr
Quarterly compound
Percentile
P90
Near historical high
vs 3Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.75% |
| Q3 2025 | 5.18% |
| Q2 2025 | 23.15% |
| Q1 2025 | -1.65% |
| Q4 2024 | 10.38% |
| Q3 2024 | 1.86% |
| Q2 2024 | 7.37% |
| Q1 2024 | 19.52% |
| Q4 2023 | -27.34% |
| Q3 2023 | 4.90% |
| Q2 2023 | 9.98% |
| Q1 2023 | 1.21% |
| Q4 2022 | 10.00% |
| Q3 2022 | 5.63% |
| Q2 2022 | -1.16% |
| Q1 2022 | 3.11% |
| Q4 2021 | 11.47% |
| Q3 2021 | -6.48% |
| Q2 2021 | -1.47% |
| Q1 2021 | 6.27% |
| Q4 2020 | -1.29% |
| Q3 2020 | 13.45% |
| Q2 2020 | -3.66% |
| Q1 2020 | 2.31% |
| Q4 2019 | 12.74% |
| Q3 2019 | -4.60% |
| Q2 2019 | 0.97% |
| Q1 2019 | 12.06% |
| Q4 2018 | 31.03% |
| Q3 2018 | 18.16% |
| Q2 2018 | -7.50% |
| Q1 2018 | 6.02% |
| Q4 2017 | -6.75% |
| Q3 2017 | 11.71% |
| Q2 2017 | 3.02% |
| Q1 2017 | 9.14% |
| Q4 2016 | 16.75% |
| Q3 2016 | 6.03% |
| Q2 2016 | -0.28% |
| Q1 2016 | 0.71% |